| Gene symbol | PSCA | Synonyms | PRO232, lncPSCA | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q24.3 | dbXrefs | |
| Description | prostate stem cell antigen | ||||
| GTO ID | GTC3399 |
| Trial ID | NCT05805371 |
| Disease | Castration-Resistant Prostate Carcinoma | Prostate Cancer | Prostate Carcinoma |
| Altered gene | PSCA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PSCA CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer |
| Year | 2023 |
| Country | United States |
| Company sponsor | City of Hope Medical Center |
| Other ID(s) | 22378|NCI-2023-02186|22378|P30CA033572 |
| Cohort 1 | |||||||||||
|
|||||||||||